Follow
Mircea T. SOFONEA
Mircea T. SOFONEA
Assoc. Prof. - Head of ETE, MIVEGEC, Univ. Montpellier, CNRS, IRD
Verified email at normalesup.org - Homepage
Title
Cited by
Cited by
Year
Optimal COVID-19 epidemic control until vaccine deployment
R Djidjou-Demasse, Y Michalakis, M Choisy, MT Sofonea, S Alizon
762020
Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021
S Alizon, S Haim-Boukobza, V Foulongne, L Verdurme, ...
Eurosurveillance 26 (28), 2100573, 2021
722021
Exposing the diversity of multiple infection patterns
MT Sofonea, S Alizon, Y Michalakis
Journal of Theoretical Biology 419, 278-289, 2017
402017
From within-host interactions to epidemiological competition: a general model for multiple infections
MT Sofonea, S Alizon, Y Michalakis
Philosophical Transactions of the Royal Society B: Biological Sciences 370 …, 2015
372015
Detecting rapid spread of SARS-cov-2 variants, france, january 26–february 16, 2021
S Haim-Boukobza, B Roquebert, S Trombert-Paolantoni, E Lecorche, ...
Emerging infectious diseases 27 (5), 1496, 2021
252021
Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic
Q Richard, S Alizon, M Choisy, MT Sofonea, R Djidjou-Demasse
PLoS computational biology 17 (3), e1008776, 2021
232021
Epidemiological monitoring and control perspectives: application of a parsimonious modelling framework to the COVID-19 dynamics in France
M Sofonea, B Reyné, B Elie, R Djidjou-Demasse, C Selinger, ...
222020
Small bottleneck size in a highly multipartite virus during a complete infection cycle
R Gallet, F Fabre, G Thébaud, MT Sofonea, A Sicard, S Blanc, ...
Journal of virology 92 (14), e00139-18, 2018
212018
Memory is key in capturing COVID-19 epidemiological dynamics
MT Sofonea, B Reyné, B Elie, R Djidjou-Demasse, C Selinger, ...
Epidemics 35, 100459, 2021
192021
The SARS-CoV-2 B. 1.351 lineage (VOC β) is outgrowing the B. 1.1. 7 lineage (VOC α) in some French regions in April 2021
B Roquebert, S Trombert-Paolantoni, S Haim-Boukobza, E Lecorche, ...
Eurosurveillance 26 (23), 2100447, 2021
172021
SARS‐CoV‐2 virulence evolution: avirulence theory, immunity and trade‐offs
S Alizon, MT Sofonea
Journal of Evolutionary Biology 34 (12), 1867-1877, 2021
142021
SARS-CoV-2 viral RNA levels are not'viral load'
Y Michalakis, MT Sofonea, S Alizon, IG Bravo
Trends in microbiology 29 (11), 970-972, 2021
122021
From Delta to Omicron: analysing the SARS-CoV-2 epidemic in France using variant-specific screening tests (September 1 to December 18, 2021)
MT Sofonea, B Roquebert, V Foulongne, L Verdurme, ...
medRxiv, 2021.12. 31.21268583, 2022
92022
Early phylodynamics analysis of the COVID-19 epidemic in France
G Danesh, B Elie, Y Michalakis, MT Sofonea, A Bal, S Behillil, G Destras, ...
Peer Community Journal 1, 2021
92021
Optimal COVID-19 epidemic control until vaccine deployment, medRxiv,(2020)
R Djidjou-Demassea, Y Michalakisa, M Choisya, MT Sofonea, S Alizon
DOI 10 (2020.04), 02-20049189, 2020
92020
SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France
B Roquebert, S Haim-Boukobza, S Trombert-Paolantoni, E Lecorche, ...
International Journal of Infectious Diseases 113, 12-14, 2021
82021
Can Ebola Virus evolve to be less virulent in humans?
MT Sofonea, L Aldakak, LFVV Boullosa, S Alizon
Journal of evolutionary biology 31 (3), 382-392, 2018
82018
Detecting within-host interactions from genotype combination prevalence data
S Alizon, CL Murall, E Saulnier, MT Sofonea
Epidemics 29, 100349, 2019
72019
Evolution Education Questionnaire on Acceptance and Knowledge (EEQ)-Standardised and ready-to-use protocols to measure acceptance of evolution and knowledge about evolution in …
A Beniermann, P Kuschmierz, R Pinxten, T Aivelo, G Bohlin, ...
COST: European cooperation in science & technology, 2021
62021
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values
S Alizon, C Selinger, MT Sofonea, S Haim-Boukobza, JM Giannoli, ...
medRxiv, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20